C4A and Huntington disease: Thus, the combined properties of the C4 scFv, notably its cytoplasmic localization, its specificity for toxic HTT fragments and its amenability toward protein engineering, suggest that this intrabody could be a valuable lead in the quest for an effective therapeutic strategy for combating HD.